[1]刘祯,赵海洋,吴环立,等.敲低WTAP表达抑制脑胶质瘤干细胞的增殖、迁移和侵袭[J].中国临床神经外科杂志,2023,28(04):263-266.[doi:10.13798/j.issn.1009-153X.2023.04.011]
　LIU Zhen,ZHAO Hai-yang,WU Huan-li,et al.Knockdown of WTAP expression inhibites proliferation, migration, and invasion of glioma stem cells[J].,2023,28(04):263-266.[doi:10.13798/j.issn.1009-153X.2023.04.011]
点击复制

敲低WTAP表达抑制脑胶质瘤干细胞的增殖、迁移和侵袭()
分享到：

《中国临床神经外科杂志》[ISSN:1009-153X/CN:42-1603/TN]

卷:
28
期数:
2023年04期
页码:
263-266
栏目:
实验研究
出版日期:
2023-04-30

文章信息/Info

Title:
Knockdown of WTAP expression inhibites proliferation, migration, and invasion of glioma stem cells
文章编号:
1009-153X（2023）04-0263-04
作者:
刘祯; 赵海洋; 吴环立; 李琳坤
473000河南，南阳市第二人民医院神经外科（刘祯、赵海洋、吴环立、李琳坤）
Author(s):
LIU Zhen;  ZHAO Hai-yang;  WU Huan-li;  LI Lin-kun
Department of Neurosurgery, Nanyang Second General Hospital, Nanyang 473000, China
关键词:
胶质瘤; 胶质瘤干细胞; 细胞增殖; 细胞侵袭; 细胞迁移; Wilms肿瘤抑制因子（WTAP）
Keywords:
Glioma;  Glioma stem cells;  Wilms tumor suppressor factor (WTAP);  Proliferation;  Migration;  Invasion
分类号:
A
DOI:
10.13798/j.issn.1009-153X.2023.04.011
文献标志码:
R739.41
摘要:
目的 探讨敲低Wilms肿瘤抑制因子（WTAP）表达对脑胶质瘤干细胞增殖、迁移和侵袭能力的影响及机制。方法 从手术切除胶质瘤标本中提取胶质瘤干细胞（GSC），应用lipofectamine2000转染WTAP shRNA质粒敲低WTAP表达，以shRNA为阴性对照；PCR检测WTAP mRNA水平分析敲低效率；MTT法检测细胞增殖能力，Transwell小室法检测细胞迁移和侵袭能力，免疫印迹法检测细胞AKT磷酸化水平。结果 从胶质瘤标本中成功提取GSC，其SOX2表达显著降低（P<0.001），而α-SMA和PDGFRb的表达上调（P<0.001）。与阴性对照组相比，WTAP敲低组GSC细胞WTAP mRNA水平明显降低（P<0.05），细胞增殖、迁移和侵袭能力均显著下降（P<0.05），细胞AKT的磷酸化水平显著降低（P<0.05）。结论 敲低WTAP表达可抑制GSC的增殖、迁移和侵袭能力，其机制可能与抑制AKT磷酸化有关。
Abstract:
Objective To investigate the effect of knockdown of Wilms tumor suppressor factor (WTAP) on proliferation, migration, and invasion of glioma stem cells and its mechanism. Methods Glioma stem cells (GSCs) were extracted from glioma specimens. WTAP shRNA plasmids were transfected into GSCs to knockdown the WTAP expression using lipofectamine2000 transfection kit. WTAP mRNA level was detected by PCR assay to analyze the efficiency of knockdown. GSCs proliferation was detected by MTT assay, migration and invasion abilities of GSCs were detected by Transwell assay, and AKT phosphorylation levels in GSCs were detected by western blotting. Results Tumor cells extracted from glioma specimens were cultured in GSC medium and showed high expression of the stem cell marker SOX2. When EGF and FGF2 were replaced with TGFβ in the medium, the expression of stem cell marker SOX2 was significantly decreased (P<0.001), while the expression of peritascular cell markers α-SMA and PDGFRb were significantly up-regulated (P<0.001). Compared with negative control group, proliferation, migration, and invasion were significantly inhibited (P<0.05), and the phosphorylation level of AKT was significantly decreased (P<0.05) in GSCs with knockdown of WTAP expression. Conclusions Knockdown of WTAP expression can inhibit the proliferation, migration, and invasion of GSCs, which may be related to the inhibition of AKT phosphorylation.

参考文献/References:

[1]Louis DN, PerryA, Wesseling P, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary [J]. Neuro Oncol, 2021， 23(8): 1231-1251.
[2]袁凡恩，陈谦学. 胶质瘤干细胞的研究进展[J]. 中国临床神经外科杂志，2016，21（8）：508-511.
[3]Cheng L, Bao SD, Rich JN. Potential therapeutic implications of cancer stem cells in glioblastoma [J]. Biochem Pharmacol, 2010, 80(5): 654-665.
[4]Jin DI, Lee SW, Han ME, et al. Expression and roles of Wilms' tumor 1-associating protein in glioblastoma [J]. Cancer Sci, 2012, 103(12): 2102-2109.
[5]Kuai Y, Gong X, Ding L, et al. Wilms' tumor 1-associating protein plays an aggressive role in diffuse large B-cell lymphoma and forms a complex with BCL6 via Hsp90 [J]. Cell Commun Signal, 2018, 16(1): 50.
[6]Tang J, Wang F, Cheng G, et al. Wilms' tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stability [J]. J Exp Clin Cancer Res, 2018, 37(1): 40.
[7]Yu HL, Ma XD, Tong JF, et al. WTAP is a prognostic marker of high-grade serous ovarian cancer and regulates the progression of ovarian cancer cells [J]. Onco Targets Therapy, 2019, 12: 6191-6201.
[8]Wei Y, Jiang Y, Zou F, et al. Activation of PI3K/Akt path-way by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells [J]. Proc Natl Acad Sci USA, 2013, 110(17): 6829-6834.
[9]张　国，易　伟. 针对脑胶质瘤相关通路治疗的研究进展[J]. 中国临床神经外科杂志，2018，23（3）：215-219.

相似文献/References:

[1]常英男　王　策　赵天书.SOX2基因在胶质瘤中的表达及生物学作用[J].中国临床神经外科杂志,2016,(05):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
　CHANG Ying-nan,WANG Ce,ZHAO Tian-shu..Expression of SOX2 gene and its biological role in human gliomas[J].,2016,(04):270.[doi:10.13798/j.issn.1009-153X.2016.05.005]
[2]赛　克　陈忠平.胶质瘤的疗效评价[J].中国临床神经外科杂志,2016,(06):321.[doi:10.13798/j.issn.1009-153X.2016.06.001]
[3]许　耿　路俊锋　杨　忠　施建斌　吴秋月　王　烨　庄冬晓　吴劲松.神经电生理监测技术在功能区胶质瘤术中的应用[J].中国临床神经外科杂志,2016,(06):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
　XU Geng,LU Jun-feng,YANG Zhong,et al.Application of intraoperative neuroelectrophysiologic monitoring to gliomas resection in eloquent function brain regions[J].,2016,(04):323.[doi:10.13798/j.issn.1009-153X.2016.06.002]
[4]李剑峰　陈银生　赛　克　张湘衡　柯　超　杨群英　牟永告　许海雄　陈忠平.173例胶质瘤预后的影响因素分析[J].中国临床神经外科杂志,2016,(06):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
　LI Jian-feng,CHEN Yin-sheng,SAI Ke,et al.Prognostic factors for gliomas: analysis of 173 cases[J].,2016,(04):327.[doi:10.13798/j.issn.1009-153X.2016.06.003]
[5]云德波　杨宇焦　张　逵　范润金　张　渊　杜贻庆.瘤周谷氨酸、天门冬氨酸水平与胶质瘤继发性 癫痫的相关性[J].中国临床神经外科杂志,2016,(06):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
　YUN De-bo,YANG Yu-Jiao,ZHANG Kui,et al.Relationship of levels of glutamate and aspartate in peritumorous tissues with seizures in patients with gliomas[J].,2016,(04):331.[doi:10.13798/j.issn.1009-153X.2016.06.004]
[6]黄书岚　成于思　王　辉　汪超甲.FAK siRNA重组质粒的构建及其对胶质瘤U251细胞 增殖及侵袭能力的抑制作用[J].中国临床神经外科杂志,2016,(06):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
　HUANG Shu-lan,CHENG Yu-si,WANG Hui,et al.Construction of siRNA recombinant plasmid targeting focal adhesion kinase gene and its effect on the proliferation and invasiveness of human glioma U251cells[J].,2016,(04):336.[doi:10.13798/j.issn.1009-153X.2016.06.006]
[7]林　雨　张　恺　李　帅　杨学军.磁共振数字化手术单元在指导胶质瘤治疗中的作用[J].中国临床神经外科杂志,2016,(06):345.[doi:10.13798/j.issn.1009-153X.2016.06.009]
[8]戴黎明　徐成仕　王泽芬　曹长军　李志强.VEGF单抗对低氧环境下C6胶质瘤细胞侵袭性的影响[J].中国临床神经外科杂志,2016,(04):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
　DAI Li-ming,XU Cheng-shi,WANG Ze-fen,et al.Effect of nonoclonal antibody of VEGF on C6 glioma cells invasiveness under hypoxia and the role of FAK/Pyk2[J].,2016,(04):219.[doi:10.13798/j.issn.1009-153X.2016.04.009]
[9]彭泽生　田道锋　张申起　陈谦学.miR-370-3p对胶质母细胞瘤U87-MG细胞株增殖能力的影响[J].中国临床神经外科杂志,2016,(04):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
　PENG Ze-sheng,TIAN Dao-feng,ZHANG Shen-qi,et al.Effects of MircoRNA-370-3p on proliferation of glioma cell line U87-MG and its potential mechanism[J].,2016,(04):223.[doi:10.13798/j.issn.1009-153X.2016.04.010]
[10]冯　驰　郭双毅　程龙海　罗　杰.氯喹通过抑制自噬促进TRAIL诱导的胶质瘤细胞凋亡[J].中国临床神经外科杂志,2016,(04):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]
　FENG Chi,GUO Shuang-yi,CHENG Long-hai,et al.Chloroquine promotes TRAIL-induced apoptosis of glioma cells through inhibition of autophagy[J].,2016,(04):227.[doi:10.13798/j.issn.1009-153X.2016.04.011]
[11]陈名宇　吴婷婷　任振华.胶质瘤干细胞表面标志物的研究进展[J].中国临床神经外科杂志,2018,(04):299.[doi:10.13798/j.issn.1009-153X.2018.04.027]
[12]孟　亮　陈谦学　余小祥　涂　勤　王跃飞　樊　文　罗才奎.MS-275对原代培养的胶质瘤细胞及其干细胞生物学行为和耐药性的影响[J].中国临床神经外科杂志,2020,(06):381.[doi:10.13798/j.issn.1009-153X.2020.06.014]
　MENG Liang,CHEN Qian-xue,YU Xiao-xiang,et al.MS-275 regulates biological behavior and drug resistance of primary cultured glioma cells and glioma stem cells through PI3K/Akt signaling pathway[J].,2020,(04):381.[doi:10.13798/j.issn.1009-153X.2020.06.014]
[13]任光辉　李武雄　齐利豪.胶质瘤干细胞外泌体通过PI3K/Akt信号通路促进胶质瘤U87细胞侵袭、迁移[J].中国临床神经外科杂志,2021,26(03):176.[doi:10.13798/j.issn.1009-153X.2021.03.011]
　REN Guang-hui,LI Wu-xiong,QI Li-hao.Glioma stem cell-derived exosomes promote glioma U87 cell invasion and migration through PI3K/Akt signaling pathway[J].,2021,26(04):176.[doi:10.13798/j.issn.1009-153X.2021.03.011]

备注/Memo

备注/Memo:
（2022-03-08收稿，2023-02-22修回）
基金项目：河南省医学科技攻关计划项目（LHGJ20200897）；南阳市科技攻关计划项目（KJGG142）
更新日期/Last Update: 2022-04-30